Referred to the House Committee on Ways and Means.
This bill amends Internal Revenue Code section 223 to treat specified fertility treatments as qualified medical expenses for Health Savings Accounts (HSAs). It defines covered services including egg/sperm/embryo preservation and storage, artificial insemination, assisted reproductive technology (including IVF), prescribed fertility medications, and gamete donation and related medical expenses.
Liberals emphasize improved access and reproductive equity benefits
Relative to its intended legislative type, this bill is a narrowly focused substantive change that clearly states its objective and supplies specific categories of fertility-related expenses to be treated as HSA-eligible, but it contains drafting imprecision and provides limited administrative, fiscal, and anti-abuse detail.
This bill amends Internal Revenue Code section 223 to treat specified fertility treatments as qualified medical expenses for Health Savings Accounts (HSAs).
It defines covered services including egg/sperm/embryo preservation and storage, artificial insemination, assisted reproductive technology (including IVF), prescribed fertility medications, and gamete donation and related medical expenses.
The change applies to amounts paid or incurred after enactment.
Content is narrowly targeted and administratively simple, improving chances, but procedural Senate hurdles and some policy objections create moderate uncertainty.
Relative to its intended legislative type, this bill is a narrowly focused substantive change that clearly states its objective and supplies specific categories of fertility-related expenses to be treated as HSA-eligible, but it contains drafting imprecision and provides limited administrative, fiscal, and anti-abuse detail.
Liberals emphasize improved access and reproductive equity benefits
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals emphasize improved access and reproductive equity benefits
Likely strongly supportive because the bill expands access to reproductive healthcare and reduces out-of-pocket costs.
It aligns with goals of reproductive autonomy, LGBTQ and single-parent family support, and removing financial barriers to fertility care.
Generally supportive but pragmatic.
Views the bill as a narrow, administrable change improving affordability, while raising reasonable concerns about equity, cost, and implementation.
Wants safeguards and data collection.
Likely skeptical or somewhat opposed.
While acknowledging family-support goals, this persona worries about expanding tax expenditures, preferential treatment for HSAs, ethical issues around gamete payments, and fiscal consequences.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Content is narrowly targeted and administratively simple, improving chances, but procedural Senate hurdles and some policy objections create moderate uncertainty.
The bill has not accumulated any surfaced votes yet.
Liberals emphasize improved access and reproductive equity benefits
Content is narrowly targeted and administratively simple, improving chances, but procedural Senate hurdles and some policy objections creat…
Relative to its intended legislative type, this bill is a narrowly focused substantive change that clearly states its objective and supplies specific categories of fertility-related expenses to be treated as HSA-eligibl…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.